An overview of vaccine development for COVID-19

- Shahcheraghi, Seyed H., Ayatollahi, Jamshid, Satija, Saurabh, Dureja, Harish, Mishra, Vijay, Almutary, Abdulmajeed G., Alnuqaydan, Abdullah M., Charbe, Nitin, Prasher, Parteek, Gupta, Gaurav, Dua, Kamal, Lotfi, Marzieh, Aljabali, Alaa A. A., Bakshi, Hamid A., Tambuwala, MM, Shastri, Madhur D., Shukla, Shakti D., Chellappan, Dinesh K., Jha, Niraj K., Anand, Krishnan, Katari, Naresh K., Mehta, Meenu

Synthesis and anticancer properties of ‘Azole’ based chemotherapeutics as emerging chemical moieties: A comprehensive review

- Prasher, Parteek, Sharma, Mousmee, Singh, Inderbir, Chellappan, Dinesh K., Dua, Kamal, Zacconi, Flavia, Gupta, Gaurav, Aljabali, Alaa A. A., Mishra, Vijay, Tambuwala, Murtaza M., Kapoor, Deepak N., Negi, Poonam, Andreoli Pinto, Terezinha de Jesus

Targeting eosinophils in respiratory diseases: biological axis, emerging therapeutics and treatment modalities

- Lee, Li-Yen, Hew, Geena Suet Yin, Singh, Pankaj Kumar, Gulati, Monica, Prasher, Parteek, Aljabali, Alaa A. A., Tambuwala, Murtaza M., Thangavelu, Lakkshmi, Panneerselvam, Jithendra, Gupta, Gaurav, Zacconi, Flavia C., Shastri, Madhur, Mehta, Meenu, Jha, Niraj Kumar, Xenaki, D, MacLoughlin, R, Oliver, BG, Chellappan, DK, Dua, Kamal, Shukla, Shakti D., Satija, Saurabh, Khurana, Navneet, Anand, Krishnan, Dureja, Harish, Singh, Sachin Kumar, Mishra, Vijay

Targeting LIN28: A new hope in prostate cancer theranostics

- Shrivastava, Garima, Aljabali, Alaa A. A., Pabari, Ritesh M., Mishra, Vijay, Almutary, Abdulmajeed G., Alnuqaydan, Abdulah M., Charbe, Nitin, Prasher, Parteek, Negi, Poonam, Goyal, Rohit, Dua, Kamal, Gupta, Gaurav, Shahcheraghi, Seyed Hossein, Serrano-Aroca, Angel, Bahar, Bojul, Barh, Debmalya, Panda, Pritam Kumar, Takayama, Kazuo, Lundstorm, Kenneth, McCarron, Paul, Bakshi, Hamid, Tambuwala, Murtaza M., Lotfi, Marzieh, Shastri, Madhur D., Shukla, Shakti D., Chellappan, Dinesh K., Jha, Niraj Kumar, Anand, Krishnan, Dureja, Harrish

Albumin nano-encapsulation of piceatannol enhances its anticancer potential in colon cancer via downregulation of nuclear p65 and HIF-1 alpha

- Aljabali, Alaa A. A., Bakshi, Hamid A., Hakkim, Faruck L., Haggag, Yusuf A., Al-Batanyeh, Khalid M., Al Zoubi, Mazhar S., Al-Trad, Bahaa, Nasef, Mohamed M., Satija, Saurabh, Mehta, Meenu, Pabreja, Kavita, Mishra, Vijay, Khan, Mohammed, Abobaker, Salem, Azzouz, Ibrahim M., Dureja, Harish, Pabari, Ritesh M., Dardouri, Ashref Ali K., Kesharwani, Prashant, Gupta, Gaurav, Shukla, Shakti Dhar, Dua, Kamal

Emerging era of "somes": polymersomes as versatile drug delivery carrier for cancer diagnostics and therapy

- Sharma, Abhishek Kumar, Prasher, Parteek, Kapoor, Deepak N., Aljabali, Alaa A., Mishra, Vijay, Gandhi, Himanshu, Kumar, Sunil, Mutalik, Srinivas, Chellappan, Dinesh Kumar, Tambuwala, Murtaza M., Dua, Kamal

Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis

- Bakshi, Hamid A., Mishra, Vijay, Rajeshkumar, S., Aljabali, Alaa A., Al-Trad, Bahaa, Pabreja, Kravita, Tambuwala, Murtaza M., Satija, Saurabh, Mehta, Meenu, Hakkim, Faruk L., Kesharwani, Prashant, Dua, Kamal, Chellappan, Dinesh K., Charbe, Nitin B., Shrivastava, Garima